Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade Gliomas
Authors:
- Madhavi TripathiMTMadhavi Tripathi
- Rajnish SharmaRSRajnish Sharma
- Maria D'SouzaMDMaria D'Souza
- Abhinav JaiminiAJAbhinav Jaimini
- Puja PanwarPPPuja Panwar
- Raunak VarshneyRVRaunak Varshney
- Anupama DattaADAnupama Datta
- Nitin KumarNKNitin Kumar
- Gunjan GargGGGunjan Garg
- Dinesh SinghDSDinesh Singh
- Rajesh K. GroverRGRajesh K. Grover
- Anil K. MishraAMAnil K. Mishra
- 1 December 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 34 (12) , 878-883
Abstract
We undertook this prospective study to compare amino acid metabolism, glucose metabolism, and proliferation in primary and recurrent low grade gliomas using positron emission tomography (PET)/computed tomography with F-18 FDOPA, F-18 FDG, and F-18 FLT. Fifteen patients with newly diagnosed or previously treated low grade gliomas (WHO grade I or II) were subjected to F-18-FDOPA, F-18 FDG, and F-18 FLT PET/computed tomography studies on consecutive days. This included 2 patients in remission as control subjects. Uptake of all the 3 tracers were analyzed visually and quantified using standardized uptake values and tumor to normal (T/N) ratios. The accuracy of all the 3 PET tracers in the detection of newly diagnosed and recurrent low grade gliomas was compared. F-18 FDOPA was positive in all cases of primary and recurrent low grade gliomas and negative in the patients in remission. Tumor was visualized on F-18 FDG in 7 of 13 cases, F-18-FLT was positive in 4 of 13 cases. Average tumor standardized uptake values max for F-18 FDOPA (5.75 +/- 4.9) and F-18 FLT (1.8 +/- 0.91) was lower than that of F-18 FDG (8.5 +/- 4.4). T/N ratios for F-18-FDOPA (2.3 +/- 0.51) and F-18 FLT (1.8 +/- 0.91) were higher than F-18 FDG (1.03 +/- 0.64) providing good image contrast for tumor detection in positive cases. F-18 FDOPA scan is superior to both F-18 FLT and F-18 FDG for visualization of primary and recurrent low grade gliomas. F-18-FLT should not be considered for evaluation of recurrent low grade gliomas.Keywords
This publication has 10 references indexed in Scilit:
- 18F-FDOPA Kinetics in Brain TumorsJournal of Nuclear Medicine, 2007
- Prediction of Pathology and Survival by FDG PET in GliomasJournal of Neuro-Oncology, 2003
- Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionineEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- 18F-FDG and 18F-FET uptake in experimental soft tissue infectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-l-DOPA11Abbreviations: AAAD, aromatic l-amino acid decarboxylase; BBB, blood-brain barrier; BUI, brain uptake index; carbidopa, l-α-hydrazino-α-methyl-β-(3,4-dihydroxyphenyl)propionic acid; l-DOPA, l-3,4-dihydroxyphenylalanine; FDA, 6-fluorodopamine; [18F]FDOPA, 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine; 4-[18F]FMT, 4-[18F]fluoro-l-meta-tyrosine; 6-[18F]FMT, 6-[18F]fluoro-l-meta-tyrosine; MeAIB, α-(methylamino)isobutyric acid; MPTP, 1-methyl-1,2,3,6-tetrahydropyridine; PD, Parkinson’s disease; PET, positron emission tomography; and PLP, pyridoxal phosphate.Biochemical Pharmacology, 2001
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- 11 C-methionine PET for differential diagnosis of low-grade gliomasNeurology, 1998
- Effects of Large Neutral Amino Acid Concentrations on 6-[F-18]Fluoro-L-DOPA KineticsJournal of Cerebral Blood Flow & Metabolism, 1998
- The use of PET in evaluating patients with primary brain tumours: is it useful?Journal of Neurology, Neurosurgery & Psychiatry, 1995